Suppression of Ulcerative Colitis in Mice by Orally Available Inhibitors of Sphingosine Kinase

Overview of attention for article published in Digestive Diseases and Sciences, December 2007

Altmetric Badge

Mentioned by

patent: 12 patents

Citations

dimensions_citation: 154 Dimensions

Readers on

mendeley: 46 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 12 patents that reference this research output.

Sphingosine pathway modulating compounds for the treatment of cancers

Grant US-11865105-B2

United States of America

Sphingosine kinase Type 1 inhibitors and uses thereof

Grant US-11737992-B2

United States of America

Sphingosine kinase type 1 inhibitors and uses thereof

Grant US-10945971-B2

United States of America

Sphingosine pathway modulating compounds for the treatment of cancers

Grant US-10881643-B2

United States of America

Sphingosine pathway modulating compounds for the treatment of cancers

Grant US-10675255-B2

United States of America

Sphingosine pathway modulating compounds for the treatment of cancers

Grant US-10660879-B2

United States of America

Sphingosine pathway modulating compounds for the treatment of cancers

Grant US-10646459-B2

United States of America

Sphingosine kinase type 1 inhibitors and uses thereof

Grant US-10624863-B2

United States of America

Sphingosine kinase type 1 inhibitors and uses thereof

Grant US-10456370-B2

United States of America

Sphingosine pathway modulating compounds for the treatment of cancers

Grant US-10278960-B2

United States of America

Sphingosine kinase type 1 inhibitors and uses thereof

Grant US-10166204-B2

United States of America

Modulation of sphingosine 1-phosphate metabolizing enzymes for the treatment of negative-st…

Grant US-9687477-B2

United States of America